Avapro (sanofi-aventis U.S. LLC)
Welcome to the PulseAid listing for the Avapro drug offered from sanofi-aventis U.S. LLC. This Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | sanofi-aventis U.S. LLC |
| NON-PROPRIETARY NAME: | irbesartan |
| SUBSTANCE NAME: | IRBESARTAN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2013-01-01 |
| END MARKETING DATE: | 0000-00-00 |
Avapro HUMAN PRESCRIPTION DRUG Details:
| Item Description | Avapro from sanofi-aventis U.S. LLC |
| LABELER NAME: | sanofi-aventis U.S. LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 75(mg/1) |
| START MARKETING DATE: | 2013-01-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0024-5850_93df66af-a5f2-41eb-98d3-000f295b9967 |
| PRODUCT NDC: | 0024-5850 |
| APPLICATION NUMBER: | NDA020757 |
Other IRBESARTAN Pharmaceutical Manufacturers / Labelers:
